Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sampling Antibiotics in Renal Replacement Therapy (SMARRT / AZUREA)
2014-002973-13Phase 4Terminated
- Sponsor
- CHU Nîmes
- Start
- Jun 2015
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of piperacillin + tazobactam, meropenem and vancomycin in Infection (3 arms), sponsored by CHU Nîmes. Primary endpoint: Pharmacokinetic parameters in RRT. Started Jun 2015; status: terminated.
02
Drugs
piperacillin + tazobactammeropenemvancomycin
03
Conditions
Infection
Beyond the preview
Go deeper on 2014-002973-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002973-13.